🔗 Permalink

Assignee profile:

Immutep S.A.S.

City:

Orsay

Country:

France

Published Applications:

Last publication date:

2023-10-19

Patent Grants:

Last grant date:

2026-04-14

Top Inventors for applications by Immutep S.A.S.

These are the the leading inventors for applications assigned to Immutep S.A.S.:

Frédéric Triebel 13 Versailles, France
Chrystelle Brignone 11 Chatenay-Malabry, France
Gerhard Johann Frey 4 San Diego, CA United States
Jennifer Marie MATARAZA 4 Cambridge, MA United States

Walter A. BLATTLER 4 Brookline, MA United States
Catherine Anne Sabatos-Peyton 3 Cambridge, MA United States
Hwai Wen Chang 3 San Marcos, CA United States
Glenn Dranoff 2 Sudbury, MA United States

Catherine Ann SABATOS-PEYTON 1 Waban, MA United States
Hwai Wen Chang 1 Cambridge, MA United States

Recent patent applications by Immutep S.A.S.

Immutep S.A.S. based in Orsay, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-10-19

US20230330182A1

Human necessities

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION

#2 | 2023-08-31

US20230272107A1

Chemistry; metallurgy

ANTI-LAG-3 ANTIBODIES

#3 | 2023-03-09

US20230074746A1

Human necessities

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION

#4 | 2022-05-19 ✅ Patent 12,600,777 granted on 2026-04-14

US20220153835A1

Chemistry; metallurgy

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3

#5 | 2021-06-17 ✅ Patent 11,684,654 granted on 2023-06-27

US20210177937A1

Human necessities

Combined preparations for the treatment of cancer or infection

#6 | 2021-01-14 ✅ Patent 12,252,535 granted on 2025-03-18

US20210009687A1

Chemistry; metallurgy

Antibody molecules to LAG-3 and uses thereof

#7 | 2020-10-15 ✅ Patent 12,214,012 granted on 2025-02-04

US20200323957A1

Human necessities

Combined preparations for the treatment of cancer

#8 | 2020-04-23 ✅ Patent 10,940,181 granted on 2021-03-09

US20200121757A1

Human necessities

Combined preparations for the treatment of cancer or infection

#9 | 2019-05-23 ✅ Patent 11,680,104 granted on 2023-06-20

US20190153112A1

Chemistry; metallurgy

Anti-LAG-3 antibodies

#10 | 2018-11-29

US20180340025A1

Chemistry; metallurgy

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3

#11 | 2018-09-27 ✅ Patent 10,874,713 granted on 2020-12-29

US20180271940A1

Human necessities

Combined preparations for the treatment of cancer or infection

#12 | 2017-07-27 ✅ Patent 9,908,936 granted on 2018-03-06

US20170210804A1

Chemistry; metallurgy

Antibody molecules to LAG-3 and uses thereof

#13 | 2016-10-27 ✅ Patent 10,736,940 granted on 2020-08-11

US20160310570A1

Human necessities

Combined preparations for the treatment of cancer

Also check out Immutep S.A.S.'s (Orsay, France) applicant profile with 11 patent applications submitted.

AssigneeID:

142190 ⎘